Publication: The results of transcatheter closure of VSD using amplatzer® device and nit occlud® Lê coil
Issued Date
2011-12-01
Resource Type
ISSN
1522726X
15221946
15221946
Other identifier(s)
2-s2.0-80055093505
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Catheterization and Cardiovascular Interventions. Vol.78, No.7 (2011), 1032-1040
Suggested Citation
Paweena Chungsomprasong, Kritvikrom Durongpisitkul, Chodchanok Vijarnsorn, Jarupim Soongswang, Trong Phi Lê The results of transcatheter closure of VSD using amplatzer® device and nit occlud® Lê coil. Catheterization and Cardiovascular Interventions. Vol.78, No.7 (2011), 1032-1040. doi:10.1002/ccd.23084 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/12185
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The results of transcatheter closure of VSD using amplatzer® device and nit occlud® Lê coil
Other Contributor(s)
Abstract
Objective: We retrospectively reviewed the result of patients who underwent transcatheter closure of ventricular septal defect (VSD) using Amplatzer® Perimembranous or Amplatzer® muscular VSD device (the Amplatzer® group) and Nit Occlud® Lê VSD Coil (the Pfm group). Background: Perimembranous type (PmVSD) and doubly committed subarterial (DCSA) VSD were the major isolated congenital heart defects in Thai children. Transcatheter device closure technique for both types of VSD has emerged as an alternative treatment to surgery. Methods: Retrospectively, data was reviewed between 2003 and 2009. Results: 116 patients were enrolled. Device or coil was successfully implanted in 94%. Complete closure at 24 hr is slightly higher in the Amplatzer® group. The average size of VSD in the Amplatzer® group was larger than the Pfm group (P = 0.001). The Pfm coil was primarily deployed in DCSA VSD when compared with the Amplatzer® group (P < 0.01). At 6 months follow-up the residual shunt was comparable (P = 0.054). There was only one transient AV block (AVB) in the Pfm group and 5 AVB in the Amplatzer® group. Four pacemakers were placed in the Amplatzer® group. Conclusions: Transcatheter closure of VSD in both Pm VSD and DCSA can be achieved by using either of the device. The Amplatzer® VSD device had the advantage of closure of larger defects with immediate less residual shunt but appeared to have a significant number of 3° AVB, which required pacemaker implantation. The Nit Occlud® Lê VSD Coil had the advantage of closure of both types of defects, in particular DCSA VSD with only small residual shunt. © 2011 Wiley Periodicals, Inc.